{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:44:44Z","timestamp":1787003084464,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A central problem in the COVID-19 pandemic is that there is not enough testing to prevent infectious spread of SARS-CoV-2, causing surges and lockdowns with human and economic toll. Molecular tests that detect viral RNAs or antigens will be unable to rise to this challenge unless testing capacity increases by at least an order of magnitude while decreasing turnaround times. Here, we evaluate an alternative strategy based on the monitoring of olfactory dysfunction, a symptom identified in 76\u201383% of SARS-CoV-2 infections\u2014including those with no other symptoms\u2014when a standardized olfaction test is used. We model how screening for olfactory dysfunction, with reflexive molecular tests, could be beneficial in reducing community spread of SARS-CoV-2 by varying testing frequency and the prevalence, duration, and onset time of olfactory dysfunction. We find that monitoring olfactory dysfunction could reduce spread via regular screening, and could reduce risk when used at point-of-entry for single-day events. In light of these estimated impacts, and because olfactory tests can be mass produced at low cost and self-administered, we suggest that screening for olfactory dysfunction could be a high impact and cost-effective method for broad COVID-19 screening and surveillance.<\/jats:p>","DOI":"10.1038\/s41467-021-23315-5","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T06:03:04Z","timestamp":1623823384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Modeling the effectiveness of olfactory testing to limit SARS-CoV-2 transmission"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5273-5234","authenticated-orcid":false,"given":"Daniel B.","family":"Larremore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Toomre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8412-4152","authenticated-orcid":false,"given":"Roy","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,16]]},"reference":[{"key":"23315_CR1","doi-asserted-by":"crossref","unstructured":"Arons, M. M. et al. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N. Engl. J. Med. 382, 2081\u20132090 (2020).","DOI":"10.1056\/NEJMoa2008457"},{"key":"23315_CR2","doi-asserted-by":"crossref","unstructured":"Sutton, D., Fuchs, K., D\u2019alton, M, & Goffman, D. Universal screening for SARS-CoV-2 in women admitted for delivery. N. Engl. J. Med. 382, 2163\u20132164 (2020).","DOI":"10.1056\/NEJMc2009316"},{"key":"23315_CR3","doi-asserted-by":"publisher","unstructured":"Oran, D. P. & Topol, E. J. Prevalence of asymptomatic SARS-CoV-2 infection: A narrative review. Ann. Intern. Med. https:\/\/doi.org\/10.7326\/M20-3012 (2020).","DOI":"10.7326\/M20-3012"},{"key":"23315_CR4","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.15585\/mmwr.mm6945a4","volume":"69","author":"P Dollard","year":"2020","unstructured":"Dollard, P. et al. Risk assessment and management of COVID-19 among travelers arriving at designated US airports, january 17\u2013september 13, 2020. Morbidity Mortal. Wkly. Rep. 69, 1681 (2020).","journal-title":"Morbidity Mortal. Wkly. Rep."},{"key":"23315_CR5","doi-asserted-by":"crossref","unstructured":"Bielecki, M. et al. Body temperature screening to identify SARS-CoV-2 infected young adult travellers is ineffective. Travel Med. Infect. Dis. 37, 101832 (2020).","DOI":"10.1016\/j.tmaid.2020.101832"},{"key":"23315_CR6","doi-asserted-by":"crossref","unstructured":"Rudolph, J. L. et al. Temperature in nursing home residents systematically tested for SARS-CoV-2. J. Am. Med. Dir. Assoc. 21, 895\u2013899 (2020).","DOI":"10.1016\/j.jamda.2020.06.009"},{"key":"23315_CR7","doi-asserted-by":"crossref","unstructured":"Vilke, G. M., Brennan, J. J., Cronin, A. O. & Castillo, E. M. Clinical features of patients with COVID-19: is temperature screening useful? J. Emerg. Med. 59, 952\u2013956 (2020).","DOI":"10.1016\/j.jemermed.2020.09.048"},{"key":"23315_CR8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1017\/S0950268816002181","volume":"145","author":"AA Chughtai","year":"2017","unstructured":"Chughtai, A. A., Wang, Q., Dung, T. C. & Macintyre, C. R. The presence of fever in adults with influenza and other viral respiratory infections. Epidemiol. Infect. 145, 148\u2013155 (2017).","journal-title":"Epidemiol. Infect."},{"key":"23315_CR9","doi-asserted-by":"publisher","first-page":"714","DOI":"10.15585\/mmwr.mm6923e4","volume":"69","author":"DC Payne","year":"2020","unstructured":"Payne, D. C. et al. SARS-CoV-2 infections and serologic responses from a sample of US navy service members-USS Theodore Roosevelt, April 2020. Morbidity Mortal. Wkly. Rep. 69, 714 (2020).","journal-title":"Morbidity Mortal. Wkly. Rep."},{"key":"23315_CR10","doi-asserted-by":"crossref","unstructured":"Lechien, J. R. et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter european study. Eur. Arch. Otorhinolaryngol. 277, 2251\u20132261 (2020).","DOI":"10.1007\/s00405-020-06024-5"},{"key":"23315_CR11","doi-asserted-by":"publisher","unstructured":"Rusetsky, Y. et al. Smell status in children infected with SARS-CoV-2. Laryngoscope. https:\/\/doi.org\/10.1002\/lary.29403 (2021).","DOI":"10.1002\/lary.29403"},{"key":"23315_CR12","unstructured":"CDC. Similarities and differences between flu and COVID-19. https:\/\/www.cdc.gov\/flu\/symptoms\/flu-vs-covid19.htm (2021)."},{"key":"23315_CR13","doi-asserted-by":"crossref","unstructured":"Pellegrino, R., Walliczek-Dworschak, U., Winter, G., Hull, D. & Hummel, T. Investigation of chemosensitivity during and after an acute cold. In International forum of allergy & rhinology, Vol. 7, 185\u2013191 (Wiley Online Library, 2017).","DOI":"10.1002\/alr.21869"},{"key":"23315_CR14","doi-asserted-by":"crossref","unstructured":"Agyeman, A. A., Chin, K. L., Landersdorfer, C. B., Liew, D. & Ofori-Asenso, R. Smell and taste dysfunction in patients with COVID-19: A systematic review and meta-analysis. In Mayo Clinic Proceedings (Elsevier, 2020).","DOI":"10.1016\/j.mayocp.2020.05.030"},{"key":"23315_CR15","first-page":"865","volume":"45","author":"ME Hannum","year":"2020","unstructured":"Hannum, M. E. et al. Objective sensory testing methods reveal a higher prevalence of olfactory loss in COVID-19 \u2013positive patients compared to subjective methods: A systematic review and meta-analysis. Chem. Senses 45, 865\u2013874 (2020).","journal-title":"Chem. Senses"},{"key":"23315_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11882-020-00972-y","volume":"20","author":"KW Pang","year":"2020","unstructured":"Pang, K. W., Chee, J., Subramaniam, S. & Ng, C. L. Frequency and clinical utility of olfactory dysfunction in COVID-19: a systematic review and meta-analysis. Curr. Allergy Asthma Rep. 20, 1\u201317 (2020).","journal-title":"Curr. Allergy Asthma Rep."},{"key":"23315_CR17","doi-asserted-by":"crossref","unstructured":"Yan, C. H., Faraji, F., Prajapati, D. P., Boone, C. E. & DeConde, A. S. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. In International Forum of Allergy & Rhinology, Vol.10, 806\u2013813 (Wiley Online Library, 2020)","DOI":"10.1002\/alr.22579"},{"key":"23315_CR18","doi-asserted-by":"publisher","unstructured":"Mazzatenta, A. et al. Smell and taste in severe COVID-19: self-reported vs. testing. Front. Med. https:\/\/doi.org\/10.3389\/fmed.2020.589409 (2020).","DOI":"10.3389\/fmed.2020.589409"},{"key":"23315_CR19","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/chemse\/bjaa066","volume":"45","author":"L Iannuzzi","year":"2020","unstructured":"Iannuzzi, L. et al. Gaining back what is lost: Recovering the sense of smell in mild to moderate patients after COVID-19. Chem. Senses 45, 875\u2013881 (2020).","journal-title":"Chem. Senses"},{"key":"23315_CR20","doi-asserted-by":"publisher","unstructured":"Bhattacharjee, A. S., Joshi, S. V., Naik, S., Sangle, S., & Abraham, N. M. Quantitative assessment of olfactory dysfunction accurately detects asymptomatic COVID-19 carriers. EClinMed. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100575 (2020).","DOI":"10.1016\/j.eclinm.2020.100575"},{"key":"23315_CR21","doi-asserted-by":"publisher","unstructured":"Butowt, R. & von Bartheld, C. S. Anosmia in COVID-19: Underlying mechanisms and assessment of an olfactory route to brain infection. Neuroscientist, https:\/\/doi.org\/10.1177\/1073858420956905 2020.","DOI":"10.1177\/1073858420956905"},{"key":"23315_CR22","doi-asserted-by":"crossref","unstructured":"Lee, Y., Min, P., Lee, S., & Kim, S.-W. Prevalence and duration of acute loss of smell or taste in COVID-19 patients. J. Korean Med. Sci. 35, e174 (2020).","DOI":"10.3346\/jkms.2020.35.e174"},{"key":"23315_CR23","doi-asserted-by":"crossref","unstructured":"Moein, S. T. et al. Smell dysfunction: a biomarker for COVID-19. In International forum of allergy & rhinology (Wiley Online Library, 2020).","DOI":"10.1002\/alr.22587"},{"key":"23315_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-18963-y","volume":"11","author":"D Pierron","year":"2020","unstructured":"Pierron, D. et al. Smell and taste changes are early indicators of the COVID-19 pandemic and political decision effectiveness. Nat. Commun. 11, 1\u20138 (2020).","journal-title":"Nat. Commun."},{"key":"23315_CR25","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1002\/lary.28964","volume":"130","author":"MM Speth","year":"2020","unstructured":"Speth, M. M. et al. Mood, anxiety and olfactory dysfunction in COVID-19: evidence of central nervous system involvement? Laryngoscope 130, 2520\u20132525 (2020).","journal-title":"Laryngoscope"},{"key":"23315_CR26","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/hed.26204","volume":"42","author":"LuigiAngelo Vaira","year":"2020","unstructured":"Vaira, L. A. et al. Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases. Head. Neck 42, 1252\u20131258 (2020).","journal-title":"Head. Neck"},{"key":"23315_CR27","doi-asserted-by":"publisher","first-page":"e58227","DOI":"10.7554\/eLife.58227","volume":"9","author":"T Wagner","year":"2020","unstructured":"Wagner, T. et al. Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis. Elife 9, e58227 (2020).","journal-title":"Elife"},{"key":"23315_CR28","doi-asserted-by":"crossref","unstructured":"Paderno, A. et al. Olfactory and gustatory outcomes in COVID-19: A prospective evaluation in nonhospitalized subjects. Otolaryngol. Head Neck Surg. 163, 1144-1149 (2020).","DOI":"10.1177\/0194599820939538"},{"key":"23315_CR29","unstructured":"Gerkin, R. C. et al. Recent smell loss is the best predictor of COVID-19 among individuals with recent respiratory symptoms. Chem. Senses 46, bjaa081 (2021)."},{"key":"23315_CR30","doi-asserted-by":"publisher","unstructured":"Larremore, D. B. et al. Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance. medRxiv https:\/\/doi.org\/10.1101\/2020.06.22.20136309 (2020).","DOI":"10.1101\/2020.06.22.20136309"},{"key":"23315_CR31","doi-asserted-by":"crossref","unstructured":"Mina, M. J., Parker, R., & Larremore, D. B. Rethinking COVID-19 test sensitivity-a strategy for containment. N. Engl. J. Med. 383, e120 (2020).","DOI":"10.1056\/NEJMp2025631"},{"key":"23315_CR32","doi-asserted-by":"publisher","first-page":"e2016818","DOI":"10.1001\/jamanetworkopen.2020.16818","volume":"3","author":"AD Paltiel","year":"2020","unstructured":"Paltiel, A. D., Zheng, A. & Walensky, R. P. Assessment of SARS-CoV-2 screening strategies to permit the safe reopening of college campuses in the united states. JAMA Netw. Open 3, e2016818\u2013e2016818 (2020).","journal-title":"JAMA Netw. Open"},{"key":"23315_CR33","doi-asserted-by":"publisher","unstructured":"Kissler, S. M. et al. Viral dynamics of SARS-CoV-2 infection and the predictive value of repeat testing. medRxiv https:\/\/doi.org\/10.1101\/2020.10.21.20217042 (2020).","DOI":"10.1101\/2020.10.21.20217042"},{"key":"23315_CR34","doi-asserted-by":"publisher","unstructured":"Cevik, M. et al. SARS-CoV-2, SARS-CoV-1 and MERS-CoV viral load dynamics, duration of viral shedding and infectiousness: a living systematic review and meta-analysis. medRxiv https:\/\/doi.org\/10.1101\/2020.07.25.20162107 (2020).","DOI":"10.1101\/2020.07.25.20162107"},{"key":"23315_CR35","first-page":"429","volume":"3","author":"AM Smith","year":"2011","unstructured":"Smith, A. M. & Perelson A. S. Influenza A virus infection kinetics: quantitative data and models. Wiley Interdiscip. Rev.: Syst. Biol. Med. 3, 429\u2013445 (2011).","journal-title":"Wiley Interdiscip. Rev.: Syst. Biol. Med."},{"key":"23315_CR36","doi-asserted-by":"publisher","unstructured":"Richard, M. et al. SARS-CoV-2 is transmitted via contact and via the air between ferrets. bioRxiv https:\/\/doi.org\/10.1101\/2020.04.16.044503 (2020).","DOI":"10.1101\/2020.04.16.044503"},{"key":"23315_CR37","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s40136-016-0120-6","volume":"4","author":"J Yang","year":"2016","unstructured":"Yang, J. & Pinto, J. M. The epidemiology of olfactory disorders. Curr. Otorhinolaryngol. Rep. 4, 130\u2013141 (2016).","journal-title":"Curr. Otorhinolaryngol. Rep."},{"key":"23315_CR38","doi-asserted-by":"crossref","unstructured":"Rebholz, H. et al. Loss of olfactory function-early indicator for COVID-19, other viral infections and neurodegenerative disorders. Front. Neurol. 11, 569333 (2020).","DOI":"10.3389\/fneur.2020.569333"},{"key":"23315_CR39","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.anl.2020.06.003","volume":"47","author":"MW El-Anwar","year":"2020","unstructured":"El-Anwar, M. W., Elzayat, S. & Fouad, Y. A. Ent manifestation in COVID-19 patients. Auris Nasus Larynx 47, 559\u2013564 (2020).","journal-title":"Auris Nasus Larynx"},{"key":"23315_CR40","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/chemse\/bjx025","volume":"42","author":"S Boesveldt","year":"2017","unstructured":"Boesveldt, S. et al. Anosmia\u2013a clinical review. Chem. Senses 42, 513\u2013523 (2017).","journal-title":"Chem. Senses"},{"key":"23315_CR41","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00405-018-5210-2","volume":"276","author":"A Hinz","year":"2019","unstructured":"Hinz, A. et al. Olfactory dysfunction: properties of the Sniffin\u2019Sticks Screening 12 test and associations with quality of life. Eur. Arch. Oto-Rhino-Laryngol. 276, 389\u2013395 (2019).","journal-title":"Eur. Arch. Oto-Rhino-Laryngol."},{"key":"23315_CR42","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1097\/00005537-200410000-00017","volume":"114","author":"BN Landis","year":"2004","unstructured":"Landis, B. N., Konnerth, C. G. & Hummel, T. J. T. L. A study on the frequency of olfactory dysfunction. Laryngoscope 114, 1764\u20131769 (2004).","journal-title":"Laryngoscope"},{"key":"23315_CR43","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00405-018-5248-1","volume":"276","author":"A Oleszkiewicz","year":"2019","unstructured":"Oleszkiewicz, A., Schriever, V. A., Croy, I., H\u00e4hner, A. & Hummel, T. Updated sniffin\u2019sticks normative data based on an extended sample of 9139 subjects. Eur. Arch. Oto-Rhino-Laryngol. 276, 719\u2013728 (2019).","journal-title":"Eur. Arch. Oto-Rhino-Laryngol."},{"key":"23315_CR44","unstructured":"The Data - The COVID Tracking Project. https:\/\/covidtracking.com\/data (2021)."},{"key":"23315_CR45","doi-asserted-by":"publisher","unstructured":"Quicke, K. et al. Longitudinal surveillance for SARS-CoV-2 RNA among asymptomatic staff in five colorado skilled nursing facilities: Epidemiologic, virologic and sequence analysis. medRxiv https:\/\/doi.org\/10.1101\/2020.06.08.20125989 (2020).","DOI":"10.1101\/2020.06.08.20125989"},{"key":"23315_CR46","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","volume":"581","author":"R W\u00f6lfel","year":"2020","unstructured":"W\u00f6lfel, R. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 581, 465\u2013469 (2020).","journal-title":"Nature"},{"key":"23315_CR47","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s10096-020-03913-9","volume":"39","author":"B La Scola","year":"2020","unstructured":"La Scola, B. et al. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur. J. Clin. Microbiol. Infect. Dis. 39, 1059 (2020).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"23315_CR48","doi-asserted-by":"publisher","unstructured":"Pilarowski, G. et al. Field performance and public health response using the BinaxNOW TM Rapid SARS-CoV-2 antigen detection assay during community-based testing. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa1890 (2020).","DOI":"10.1093\/cid\/ciaa1890"},{"key":"23315_CR49","doi-asserted-by":"publisher","unstructured":"Larremore, D. B., Toomre, D. & Parker, R. Modeling the effectiveness of olfactory testing to limit SARS-CoV-2 transmission, code repository. https:\/\/doi.org\/10.1101\/2020.11.30.20241174 (2021).","DOI":"10.1101\/2020.11.30.20241174"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23315-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23315-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23315-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T07:52:13Z","timestamp":1669967533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23315-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,16]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["23315"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-23315-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.11.30.20241174","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,16]]},"assertion":[{"value":"20 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.B.L. is a member of the scientific advisory board of Darwin BioSciences. D.T. declares competing interests as a founder of olfactory test company (u-Smell-it<sup>TM<\/sup>LLC) and for EU patent (DM\/212486) and pending US patents (29,743,100 and 29,750,313) that relate to an inexpensive multi-odorant olfactory test and software interface. R.P. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3664"}}